Theravance Biopharma, Inc. (TBPH)

16.89 -0.05 (-0.30%) USD  |  NASDAQ  |  May 07, 12:13
More

Theravance Biopharma SG&A Expense (TTM) : 78.40M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Integer Holdings Corp. 219.30M
Catalyst Pharmaceuticals, Inc. 171.18M
QuidelOrtho Corp. 559.30M
Viatris, Inc. 3.794B
Relmada Therapeutics, Inc. 32.22M